{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:52:21Z","timestamp":1789645941314,"version":"4.0.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,7,30]],"date-time":"2010-07-30T00:00:00Z","timestamp":1280448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s11926-010-0119-9","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T05:31:35Z","timestamp":1280381495000},"page":"386-393","source":"Crossref","is-referenced-by-count":27,"title":["Metabolic Myopathies"],"prefix":"10.1007","volume":"12","author":[{"given":"Salvatore","family":"DiMauro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Garone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Naini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,30]]},"reference":[{"key":"119_CR1","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa066691","volume":"357","author":"G Kollberg","year":"2007","unstructured":"Kollberg G, Tulinius M, Gilljam T, et al.: Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0. N Engl J Med 2007, 357:1507\u20131514.","journal-title":"N Engl J Med"},{"key":"119_CR2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ygeno.2008.01.011","volume":"91","author":"ME McCue","year":"2008","unstructured":"McCue ME, Valberg SJ, Miller MB, et al.: Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis. Genomics 2008, 91:458\u2013466.","journal-title":"Genomics"},{"key":"119_CR3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1432-1033.1988.tb14294.x","volume":"176","author":"J Pitcher","year":"1988","unstructured":"Pitcher J, Smythe C, Cohen P: Glycogenin is the priming glucosyltransferase required for the initiation of glycogen biogenesis in rabbit skeletal muscle. Eur J Biochem 1988, 176:391\u2013395.","journal-title":"Eur J Biochem"},{"key":"119_CR4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMoa0900661","volume":"362","author":"A-R Moslemi","year":"2010","unstructured":"\u2022\u2022 Moslemi A-R, Lindberg C, Nilsson J, et al.: Glycogenin-1 deficiency and inactivated priming of glycogen synthesis. N Engl J Med 2010, 362:1203\u20131210. These are the long-awaited first mutations in the muscle glycogenin gene and the second example of \u201cglycogenosis 0\u201d in human muscle.","journal-title":"N Engl J Med"},{"key":"119_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMc0901158","volume":"361","author":"T Stojkovic","year":"2009","unstructured":"\u2022\u2022 Stojkovic T, Vissing J, Petit F, et al.: Muscle glycogenosis due to phosphoglucomutase 1 deficiency. N Engl J Med 2009, 361:425\u2013427. This is a new glycolytic defect showing the \u201ctypical\u201d syndrome of exercise intolerance, cramps, and recurrent myoglobinuria.","journal-title":"N Engl J Med"},{"key":"119_CR6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1212\/WNL.38.4.602","volume":"38","author":"H Sugie","year":"1988","unstructured":"Sugie H, Kobayashi J, Sugie Y, et al.: Infantile muscle glycogen storage disease: phosphoglucomutase deficiency with decreased muscle and serum carnitine. Neurology 1988, 38:602\u2013605.","journal-title":"Neurology"},{"key":"119_CR7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mus.21351","volume":"40","author":"AA Nadaj-Pakleza","year":"2009","unstructured":"Nadaj-Pakleza AA, Vincitorio CM, Laforet P, et al.: Permanent muscle weakness in McArdle disease. Muscle Nerve 2009, 40:350\u2013357.","journal-title":"Muscle Nerve"},{"key":"119_CR8","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/brain\/awp065","volume":"132","author":"J Vissing","year":"2009","unstructured":"\u2022 Vissing J, Duno M, Schwartz M, Haller RG: Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease. Brain 2009, 132:1545\u20131552. This is an interesting genotype\u2013phenotype association documenting that even a very small amount of residual enzyme activity ameliorates the clinical presentation.","journal-title":"Brain"},{"key":"119_CR9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/01.wnl.0000343002.74480.e4","volume":"72","author":"MC Orngreen","year":"2009","unstructured":"Orngreen MC, Jeppesen TD, Tvede Andersen S, et al.: Fat metabolism during exercise in patients with McArdle diseae. Neurology 2009, 72:718\u2013724.","journal-title":"Neurology"},{"key":"119_CR10","doi-asserted-by":"crossref","unstructured":"Quinlivan R, Beynon RJ: Pharmacological and nutritional treatment for McArdle\u2019s disease (glycogen storage disease type V). Cochrane Database Syst Rev 2004, 3:CD003458.","DOI":"10.1002\/14651858.CD003458.pub2"},{"key":"119_CR11","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Ploeg van der","year":"2010","unstructured":"\u2022 van der Ploeg AT, Clemens PR, Corzo D, et al.: A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med 2010, 362:1396\u20131406. This is the first (but probably not the last) multicentric study of enzyme replacement therapy in glycogenosis type II.","journal-title":"N Engl J Med"},{"key":"119_CR12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2009.08.003","volume":"99","author":"PS Kishnani","year":"2010","unstructured":"Kishnani PS, Goldenberg PC, DeArmey SL, et al.: Cross-reacting immunological material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab 2010, 99:26\u201333.","journal-title":"Mol Genet Metab"},{"key":"119_CR13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1056\/NEJMc0806809","volume":"360","author":"NJ Mendelsohn","year":"2009","unstructured":"Mendelsohn NJ, Messinger YH, Rosenberg A, Kishnani P: Elimination of antibodies to recombinant enzyme in Pompe\u2019s disease. N Engl J Med 2009, 360:194\u2013195.","journal-title":"N Engl J Med"},{"key":"119_CR14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","volume":"1","author":"G Parenti","year":"2009","unstructured":"Parenti G: Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics. EMBO Mol Med 2009, 1:268\u2013279.","journal-title":"EMBO Mol Med"},{"issue":"Suppl 5","key":"119_CR15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1528-1167.2009.02117.x","volume":"50","author":"N Ramachandran","year":"2009","unstructured":"\u2022 Ramachandran N, Girard J-M, Turnbull J, Minassian B: The autosomal recessively inherited progressive myoclonus epilepsies and their genes. Epilepsia 2009, 50(Suppl 5):29\u201336. This is an excellent critical review of Lafora\u2019s disease and other progressive myoclonic epilepsies.","journal-title":"Epilepsia"},{"key":"119_CR16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mus.21167","volume":"39","author":"A Ohkuma","year":"2009","unstructured":"\u2022 Ohkuma A, Noguchi S, Sugie H, et al.: Clinical and genetic analysis of lipid storage myopathies. Muscle Nerve 2009, 39:333\u2013342. This is an excellent systematic analysis of a large cohort of patients with LSM and a critical review of the subject.","journal-title":"Muscle Nerve"},{"key":"119_CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/GIM.0b013e3181c5e6f7","volume":"12","author":"AW el-Hattab","year":"2010","unstructured":"el-Hattab AW, Li F-Y, Shen J, et al.: Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. Genet Med 2010, 12:19\u201324.","journal-title":"Genet Med"},{"key":"119_CR18","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bbrc.2008.03.010","volume":"369","author":"C Bruno","year":"2008","unstructured":"\u2022 Bruno C, Bertini E, Di Rocco M, et al.: Clinical and genetic characterization of Chanarin-Dorfman syndrome. Biochem Biophys Res Comm 2008, 369:1125\u20131128. This is an excellent review of Chanarin-Dorfman syndrome.","journal-title":"Biochem Biophys Res Comm"},{"key":"119_CR19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nmd.2010.04.004","volume":"20","author":"HO Akman","year":"2010","unstructured":"\u2022\u2022 Akman HO, Davidzon G, Tanji K, et al.: Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene. Neuromuscul Disord 2010, 20:397\u2013402. This article discussed an interesting presymptomatic patient with an unusual mutation and a problematic disconnect between muscle biopsy and normal strength.","journal-title":"Neuromuscul Disord"},{"key":"119_CR20","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/brain\/awm054","volume":"130","author":"K Gempel","year":"2007","unstructured":"Gempel K, Topaloglu H, Talim B, et al.: The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 2007, 130:2037\u20132044.","journal-title":"Brain"},{"key":"119_CR21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nmd.2009.01.008","volume":"19","author":"W-C Liang","year":"2009","unstructured":"Liang W-C, Ohkuma A, Hayashi YK, et al.: ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency. Neuromuscul Disord 2009, 19:212\u2013216.","journal-title":"Neuromuscul Disord"},{"key":"119_CR22","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1056\/NEJMc0806334","volume":"360","author":"J-P Bonnefont","year":"2009","unstructured":"\u2022 Bonnefont J-P, Bastin J, Behin A, Djouadi F: Bezafibrate for an inborn mitochondrial beta-oxidation defect. N Engl J Med 2009, 360:838\u2013840. This article discusses a convincing and promising therapeutic approach to an inborn error of metabolism.","journal-title":"N Engl J Med"},{"key":"119_CR23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1212\/01.wnl.0000318283.42961.e9","volume":"71","author":"CR Roe","year":"2008","unstructured":"Roe CR, Yang B-Z, Brunengraber H, et al.: Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy. Neurology 2008, 71:260\u2013264.","journal-title":"Neurology"},{"key":"119_CR24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.21217","volume":"63","author":"AM Schaefer","year":"2008","unstructured":"Schaefer AM, McFarland R, Blakely E, et al.: Prevalence of mitochondrial DNA disease in adults. Ann Neurol 2008, 63:35\u201339.","journal-title":"Ann Neurol"},{"key":"119_CR25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ajhg.2008.07.004","volume":"83","author":"HR Elliott","year":"2008","unstructured":"\u2022\u2022 Elliott HR, Samuels DC, Eden JA, et al.: Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008, 83:254\u2013260. This article presented astonishing results of a simple but long overdue survey of healthy newborns showing an unexpectedly high prevalence of mtDNA pathogenic mutations.","journal-title":"Am J Hum Genet"},{"key":"119_CR26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archneurol.2008.526","volume":"66","author":"P Kaufmann","year":"2009","unstructured":"\u2022 Kaufmann P, Engelstad K, Wei Y, et al.: Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol 2009, 66:85\u201391. This study provided interesting documentation of the clinical spectrum of the common MELAS mutation in a large cohort of mutation carriers.","journal-title":"Arch Neurol"},{"key":"119_CR27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.mito.2009.08.006","volume":"9","author":"MM Davidson","year":"2009","unstructured":"\u2022 Davidson MM, Walker WF, Hernandez-Rosa E: The m.3243A>G mtDNA mutation is pathogenic in an in vitro model of the human blood brain barrier. Mitochondrion 2009, 9:463\u2013470. This article presented elegant in vitro modeling of the human BBB and a promising tool for studies of pathogenesis and therapeutic strategies.","journal-title":"Mitochondrion"},{"key":"119_CR28","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/brain\/awp221","volume":"132","author":"R Horvath","year":"2009","unstructured":"\u2022\u2022 Horvath R, Kemp JP, Tuppen HAL, et al.: Molecular basis of infantile reversible cytochrome c oxidase deficiency. Brain 2009, 132:3165\u20133174. This was a fascinating example of the complex interaction between the nuclear and mitochondrial genomes.","journal-title":"Brain"},{"key":"119_CR29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ymgme.2010.03.015","volume":"100","author":"SJG Hoefs","year":"2010","unstructured":"Hoefs SJG, Skjeldal OH, Rodenburg RJ, et al.: Novel mutations in the NDUFS1 gene cause low residual activities in human complex I deficiencies. Mol Gen Metab 2010, 100:251\u2013256.","journal-title":"Mol Gen Metab"},{"key":"119_CR30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajhg.2007.12.024","volume":"82","author":"C Lagier-Tourenne","year":"2008","unstructured":"Lagier-Tourenne C, Tazir M, Lopez LC, et al.: ADSK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 2008, 82:661\u2013672.","journal-title":"Am J Hum Genet"},{"key":"119_CR31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2007.12.022","volume":"82","author":"J Mollet","year":"2008","unstructured":"Mollet J, Delahodde A, Serre V, et al.: CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 2008, 82:623\u2013630.","journal-title":"Am J Hum Genet"},{"key":"119_CR32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ajhg.2009.03.018","volume":"84","author":"AJ Duncan","year":"2009","unstructured":"Duncan AJ, Bitner-Glindziez M, Meunier B, et al.: A nonsense mutation in COQ9 causes autosomal recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am J Hum Genet 2009, 84:558\u2013566.","journal-title":"Am J Hum Genet"},{"key":"119_CR33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nmd.2009.10.014","volume":"20","author":"S Sacconi","year":"2010","unstructured":"\u2022 Sacconi S, Trevisson E, Salviati L, et al.: Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord 2010, 20:44\u201348. This was an interesting collaborative study documenting secondary CoQ 10 deficiency in patients with primary mitochondrial myopathy.","journal-title":"Neuromuscul Disord"},{"key":"119_CR34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.clinbiochem.2008.12.010","volume":"42","author":"MD Cordero","year":"2009","unstructured":"Cordero MD, Moreno-Fernandez AM, deMiguel M, et al.: Coenzyme Q10 distribution is altered in patients with fibromyalgia. Clin Biochem 2009, 42:732\u2013735.","journal-title":"Clin Biochem"},{"key":"119_CR35","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.ajhg.2008.05.002","volume":"82","author":"V Massa","year":"2008","unstructured":"\u2022\u2022 Massa V, Fernandez-Vizarra E, Alshahwan S, et al.: Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase. Am J Hum Genet 2008, 82:1281\u20131289. This study was a historical \u201cfirst\u201d showing that mutations affecting COX subunits directly do occur.","journal-title":"Am J Hum Genet"},{"key":"119_CR36","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ajhg.2008.09.009","volume":"83","author":"C Sugiana","year":"2008","unstructured":"Sugiana C, Pagliarini DJ, McKenzie M, et al.: Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease. Am J Hum Genet 2008, 83:468\u2013478.","journal-title":"Am J Hum Genet"},{"key":"119_CR37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajhg.2007.08.003","volume":"82","author":"A Saada","year":"2008","unstructured":"Saada A, Edvardson S, Rapaport M, et al.: C6ORF66 is an assembly factor of mitochondrial complex I. Am J Hum Genet 2008, 82:32\u201338.","journal-title":"Am J Hum Genet"},{"key":"119_CR38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/ng.390","volume":"41","author":"W Weraarpachai","year":"2009","unstructured":"\u2022\u2022 Weraarpachai W, Antonicka H, Sasarman F, et al.: Mutation in TACO1, encoding a translational activator of COX I, results in cytochrome c oxidase deficiency and late-onset Leigh syndrome. Nat Genet 2009, 41:833\u2013837. This was the first demonstration that \u201cindirect hits\u201d can affect isolated subunits of RC complexes.","journal-title":"Nat Genet"},{"key":"119_CR39","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ng.246","volume":"40","author":"A Cizkova","year":"2009","unstructured":"Cizkova A, Stranecky V, Mayr JA, et al.: TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalomyopathy. Nat Genet 2009, 40:1288\u20131290.","journal-title":"Nat Genet"},{"key":"119_CR40","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awq007","volume":"133","author":"P Yu-Wai-Man","year":"2010","unstructured":"\u2022\u2022 Yu-Wai-Man P, Griffiths PG, Gorman GS, et al.: Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010, 133:771\u2013786. This was an important demonstration of the protean phenotypic expression of OPA1 mutations.","journal-title":"Brain"},{"key":"119_CR41","doi-asserted-by":"crossref","unstructured":"\u2022 Smits P, Smeitink JAM, van den Heuvel B: Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies. J Biomed Biotechnol 2010 Apr 13 (Epub ahead of print). This is a comprehensive and comprehensible review of a complex subject.","DOI":"10.1155\/2010\/737385"},{"key":"119_CR42","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1093\/hmg\/ddp326","volume":"18","author":"H Chen","year":"2009","unstructured":"\u2022 Chen H, Chan DC: Mitochondrial dynamics\u2014fusion, fission, movement, and mitophagy\u2014in neurodegenerative diseases. Hum Mol Genet 2009, 18:R169\u2013R176. This is a lucid review of mitochondrial dynamics gone awry.","journal-title":"Hum Mol Genet"},{"key":"119_CR43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1750-3639.1992.tb00683.x","volume":"2","author":"J Muller-Hocker","year":"1992","unstructured":"Muller-Hocker J: Mitochondria and ageing. Brain Pathol 1992, 2:149\u2013158.","journal-title":"Brain Pathol"},{"key":"119_CR44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2008.07.006","volume":"8","author":"T Wenz","year":"2008","unstructured":"\u2022\u2022 Wenz T, Diaz F, Spiegelman BM, Moraes CT: Activation of the PPAR\/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab 2008, 8:249\u2013255. This is an elegant demonstration of how enhancing mitochondrial biogenesis can benefit an RC defect.","journal-title":"Cell Metab"},{"key":"119_CR45","doi-asserted-by":"crossref","first-page":"20405","DOI":"10.1073\/pnas.0911570106","volume":"106","author":"T Wenz","year":"2009","unstructured":"Wenz T, Rossi S, Rotundo RL, et al.: Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A 2009, 106:20405\u201320410.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"119_CR46","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1152\/japplphysiol.91571.2008","volume":"106","author":"T Wenz","year":"2009","unstructured":"\u2022 Wenz T, Diaz F, Hernandez D, Moraes CT: Endurance exercise is protective for mice with mitochondrial myopathy. J Appl Physiol 2009, 106:1712\u20131719. This article explains why aerobic exercise is beneficial in mitochondrial myopathies.","journal-title":"J Appl Physiol"},{"key":"119_CR47","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pmed.0040076","volume":"4","author":"AE Civitarese","year":"2007","unstructured":"Civitarese AE, Carling S, Heilbronn LK, et al.: Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med 2007, 4:e76.","journal-title":"PLoS Med"},{"key":"119_CR48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/nbm.1315","volume":"22","author":"SS Mathew","year":"2009","unstructured":"Mathew SS, Mao X, Keegan KA, et al.: Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T 1H MRS imaging study. NMR Biomed 2009; 22:251\u2013258.","journal-title":"NMR Biomed"},{"key":"119_CR49","first-page":"1","volume":"2","author":"S Myhill","year":"2009","unstructured":"Myhill S, Booth NE, McLaren-Howard J: Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med 2009, 2:1\u201316.","journal-title":"Int J Clin Exp Med"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-010-0119-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-010-0119-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-010-0119-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:49:53Z","timestamp":1559422193000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-010-0119-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,30]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["119"],"URL":"https:\/\/doi.org\/10.1007\/s11926-010-0119-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,30]]}}}